| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/2007 | CA2297326C Heterocyclic compound and antitumor agent containing the same as active component |
| 03/20/2007 | CA2278509C Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof |
| 03/20/2007 | CA2273985C Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 03/20/2007 | CA2239424C Stabilized skin conditioner with alpha hydroxy acids |
| 03/20/2007 | CA2211320C 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 |
| 03/20/2007 | CA2206699C 7-alkylidene cephalosporanic acid derivatives and methods of using the same |
| 03/20/2007 | CA2205868C Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 03/20/2007 | CA2180352C A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
| 03/20/2007 | CA2164798C Novel erythromycin derivatives, process for preparing the same and their use as drugs |
| 03/20/2007 | CA2162154C Use of a transition metal complex for the treatment of septic shock |
| 03/20/2007 | CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/16/2007 | WO2006028277A1 A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 03/15/2007 | WO2007030834A1 Chimeric hcn channels |
| 03/15/2007 | WO2007030804A1 Prion-specific peptoid reagents |
| 03/15/2007 | WO2007030800A2 Acute treatment of social phobia |
| 03/15/2007 | WO2007030780A2 Quinoline derivatives and use as antitumor agents |
| 03/15/2007 | WO2007030777A2 Amide and carbamate derivatives of alkyl substituted n-[4-(4-amino-1h-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods |
| 03/15/2007 | WO2007030775A2 Amide and carbamate derivatives of n-{2-[4-amino-2- (ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods |
| 03/15/2007 | WO2007030770A2 Endothelin receptors in morphine withdrawal |
| 03/15/2007 | WO2007030721A2 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 03/15/2007 | WO2007030718A2 Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same |
| 03/15/2007 | WO2007030697A2 Modulation of neurogenesis by hdac inhibition |
| 03/15/2007 | WO2007030680A2 Triazole derivatives useful as axl inhibitors |
| 03/15/2007 | WO2007030657A1 CRYSTALLINE FORMS OF [1S-(1α, 3α, 4β)]-2- AMINO-1,9-DIHYDRO-9-[4-HYDROXY-3-(HYDROXYMETHYL)-2- METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE |
| 03/15/2007 | WO2007030618A2 Bicyclic derivatives as modulators of voltage gated ion channels |
| 03/15/2007 | WO2007030617A1 Inhibitors of bacterial impdh |
| 03/15/2007 | WO2007030574A2 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 03/15/2007 | WO2007030559A2 1, 3-disubstituted indole derivatives for use as ppar modulators |
| 03/15/2007 | WO2007030538A2 Functionalized drugs and polymers derived therefrom |
| 03/15/2007 | WO2007030537A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | WO2007030464A2 Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices |
| 03/15/2007 | WO2007030460A2 Hydrophobic polysaccharide derivatives |
| 03/15/2007 | WO2007030455A2 Mutations and polymorphisms of hdac10 |
| 03/15/2007 | WO2007030377A1 Substituted benzimidazoles as kinase inhibitors |
| 03/15/2007 | WO2007030362A1 Ikk inhibitors for the treatment of endometriosis |
| 03/15/2007 | WO2007030361A2 Benzimidazole thiophene compounds as plk inhibitors |
| 03/15/2007 | WO2007030360A2 P13k inhibitors for the treatment of endometriosis |
| 03/15/2007 | WO2007030359A1 Benzimidazole thiophene compounds as plk modulators |
| 03/15/2007 | WO2007030302A2 Drugs coated on a device to treat vulnerable plaque |
| 03/15/2007 | WO2007030150A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
| 03/15/2007 | WO2007030145A2 Elastin protective polyphenolics and methods of using the same |
| 03/15/2007 | WO2007030108A1 Vitamin b-12 compositions |
| 03/15/2007 | WO2007030107A1 Combination therapy for treatment of high cholesterol |
| 03/15/2007 | WO2007030083A2 N-(1-pyrene)maleimide, iaans and 5- (bromomethyl) fluorescein for covalent binding to md-2 and effect on the immune response |
| 03/15/2007 | WO2007030080A1 Heterocyclic compounds |
| 03/15/2007 | WO2007030061A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 03/15/2007 | WO2007030023A1 A medical composition for treating wounds |
| 03/15/2007 | WO2007029889A1 Protective action of serofendic acid on cardiac muscle |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2007029781A1 Adhesive preparation containing bisoprolol |
| 03/15/2007 | WO2007029760A1 Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 03/15/2007 | WO2007029730A1 Amino acid composition for prevention or treatment of senile anemia |
| 03/15/2007 | WO2007029642A1 Remedy for osteoporosis with the use of retinoid x receptor-related compound |
| 03/15/2007 | WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 03/15/2007 | WO2007029627A1 Green alga extract with high astaxanthin content and method of producing the same |
| 03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
| 03/15/2007 | WO2007029361A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same |
| 03/15/2007 | WO2007029345A1 Tyrosinase activity inhibitor |
| 03/15/2007 | WO2007029258A2 Use of lipid conjugates in the treatment of infection |
| 03/15/2007 | WO2007029255A1 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients |
| 03/15/2007 | WO2007029251A2 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase |
| 03/15/2007 | WO2007029238A2 Methods and compositions for oral administration of proteins |
| 03/15/2007 | WO2007029107A1 Isoquinolines derivatives as igf-1r inhibitors |
| 03/15/2007 | WO2007029106A1 Isoquinolines as igf-1r inhibitors |
| 03/15/2007 | WO2007029098A1 Liquid filled delivery system, preferably an hpmc capsule filled with glycerol |
| 03/15/2007 | WO2007029077A1 Substituted indazoles as inhibitors of phosphodiesterase type-iv |
| 03/15/2007 | WO2007029076A1 Isoindole derivatives as antimicrobial agents |
| 03/15/2007 | WO2007029029A2 Tetracyclic indole derivatives as antiviral agents |
| 03/15/2007 | WO2007029021A1 1,5-substituted tetrazoles as therapeutic compounds |
| 03/15/2007 | WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists |
| 03/15/2007 | WO2007028905A1 Use of agomelatine in order to obtain medicaments which are intended for the treatment of sleep disorders among depressed patients |
| 03/15/2007 | WO2007028904A1 Novel combination between agomelatine and a noradrenaline reuptake inhibitor and pharmaceutical compositions containing same |
| 03/15/2007 | WO2007028903A1 Novel combination between agomelatine and a thymoregulating agent and pharmaceutical compositions containing same |
| 03/15/2007 | WO2007028849A1 Pyrazolecarboxamide derivatives, method of obtaining same and use thereof as inverse antagonists/agonists of the cannabinoid cb1 and opioid mu receptor |
| 03/15/2007 | WO2007028821A2 Treatment of autoimmune diseases |
| 03/15/2007 | WO2007028814A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 03/15/2007 | WO2007028812A2 Selected cgrp antagonists method for production and use thereof as medicament |
| 03/15/2007 | WO2007028789A1 Quinazoline derivatives as antiviral agents |
| 03/15/2007 | WO2007028788A1 New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture |
| 03/15/2007 | WO2007028770A1 Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease |
| 03/15/2007 | WO2007028769A1 Monoamine neurotransmitter re-uptake inhibitor for neuroprotection |
| 03/15/2007 | WO2007028654A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 03/15/2007 | WO2007028638A1 Fused and spirocycle compounds and the use thereof |
| 03/15/2007 | WO2007028520A1 Iminooxazolidine derivatives and use thereof |
| 03/15/2007 | WO2007028513A2 Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient |
| 03/15/2007 | WO2007028460A1 TETRAHYDRO-β-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS |
| 03/15/2007 | WO2007028456A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
| 03/15/2007 | WO2007028445A1 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives |
| 03/15/2007 | WO2007028424A1 Amide derivatives as ppar activators |
| 03/15/2007 | WO2007028413A1 Pharmaceutical composition suitable for the treatment of malaria within one day |
| 03/15/2007 | WO2007028341A1 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids |
| 03/15/2007 | WO2007028256A2 Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
| 03/15/2007 | WO2007028247A1 Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| 03/15/2007 | WO2007028244A1 Modified biodegradable polymers, preparation and use thereof for making biomaterials and dressings |
| 03/15/2007 | WO2007028196A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 03/15/2007 | WO2007016674A3 2-aminoaryl pyridines as protein kinases inhibitors |
| 03/15/2007 | WO2007013078A3 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 03/15/2007 | WO2007011575A3 Method and composition for bone growth |
| 03/15/2007 | WO2007010312A3 Use of mmp inhibitors for the preparation of pharmaceutical compositions of cardioprotective effect |
| 03/15/2007 | WO2007008627A3 Apoptosis promoters |